nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0744	0.0744	CbGpPWpGaD
Simvastatin—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0633	0.0633	CbGpPWpGaD
Simvastatin—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0514	0.0514	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—MB21D1—conduct disorder	0.0358	0.0358	CbGpPWpGaD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0302	0.0302	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—POLR3A—conduct disorder	0.0263	0.0263	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—WASF1—conduct disorder	0.0221	0.0221	CbGpPWpGaD
Simvastatin—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.0209	0.0209	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—MB21D1—conduct disorder	0.0208	0.0208	CbGpPWpGaD
Simvastatin—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Simvastatin—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0178	0.0178	CbGpPWpGaD
Simvastatin—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0164	0.0164	CbGpPWpGaD
Simvastatin—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.0156	0.0156	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—POLR3A—conduct disorder	0.0153	0.0153	CbGpPWpGaD
Simvastatin—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Simvastatin—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0145	0.0145	CbGpPWpGaD
Simvastatin—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Simvastatin—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—WASF1—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Simvastatin—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Simvastatin—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.0124	0.0124	CbGpPWpGaD
Simvastatin—UGT1A3—Biological oxidations—COMT—conduct disorder	0.0122	0.0122	CbGpPWpGaD
Simvastatin—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.0121	0.0121	CbGpPWpGaD
Simvastatin—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.0121	0.0121	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0104	0.0104	CbGpPWpGaD
Simvastatin—UGT2B7—Biological oxidations—COMT—conduct disorder	0.0104	0.0104	CbGpPWpGaD
Simvastatin—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Simvastatin—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Simvastatin—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00982	0.00982	CbGpPWpGaD
Simvastatin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0096	0.0096	CbGpPWpGaD
Simvastatin—HMGCR—PPARA activates gene expression—EP300—conduct disorder	0.0092	0.0092	CbGpPWpGaD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.009	0.009	CbGpPWpGaD
Simvastatin—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00845	0.00845	CbGpPWpGaD
Simvastatin—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00839	0.00839	CbGpPWpGaD
Simvastatin—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00833	0.00833	CbGpPWpGaD
Simvastatin—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00832	0.00832	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0077	0.0077	CbGpPWpGaD
Simvastatin—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00742	0.00742	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00714	0.00714	CbGpPWpGaD
Simvastatin—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00711	0.00711	CbGpPWpGaD
Simvastatin—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00706	0.00706	CbGpPWpGaD
Simvastatin—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00701	0.00701	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00687	0.00687	CbGpPWpGaD
Simvastatin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00683	0.00683	CbGpPWpGaD
Simvastatin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00677	0.00677	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00659	0.00659	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00625	0.00625	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.0062	0.0062	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—EP300—conduct disorder	0.00593	0.00593	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00587	0.00587	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CGA—conduct disorder	0.00568	0.00568	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EP300—conduct disorder	0.00534	0.00534	CbGpPWpGaD
Simvastatin—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00526	0.00526	CbGpPWpGaD
Simvastatin—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00522	0.00522	CbGpPWpGaD
Simvastatin—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00518	0.00518	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00514	0.00514	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.0051	0.0051	CbGpPWpGaD
Simvastatin—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00507	0.00507	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CGA—conduct disorder	0.00463	0.00463	CbGpPWpGaD
Simvastatin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00446	0.00446	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00445	0.00445	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00442	0.00442	CbGpPWpGaD
Simvastatin—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00439	0.00439	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00397	0.00397	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CGA—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Simvastatin—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00392	0.00392	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00365	0.00365	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00363	0.00363	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00362	0.00362	CbGpPWpGaD
Simvastatin—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.0036	0.0036	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00358	0.00358	CbGpPWpGaD
Simvastatin—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00357	0.00357	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CGA—conduct disorder	0.00343	0.00343	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CGA—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EP300—conduct disorder	0.00311	0.00311	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00308	0.00308	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CGA—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CGA—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—COMT—conduct disorder	0.00257	0.00257	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—MAOA—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Simvastatin—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00239	0.00239	CbGpPWpGaD
Simvastatin—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Simvastatin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00236	0.00236	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—COMT—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—MAOA—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CGA—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CGA—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—COMT—conduct disorder	0.00178	0.00178	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—MAOA—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CGA—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—COMT—conduct disorder	0.00155	0.00155	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—MAOA—conduct disorder	0.00154	0.00154	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00153	0.00153	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CGA—conduct disorder	0.00147	0.00147	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—COMT—conduct disorder	0.00145	0.00145	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—MAOA—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CGA—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CGA—conduct disorder	0.00137	0.00137	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—COMT—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—MAOA—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00128	0.00128	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—COMT—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—MAOA—conduct disorder	0.00121	0.00121	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—EP300—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CGA—conduct disorder	0.000905	0.000905	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—COMT—conduct disorder	0.000899	0.000899	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—EP300—conduct disorder	0.000897	0.000897	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—MAOA—conduct disorder	0.000892	0.000892	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—COMT—conduct disorder	0.000878	0.000878	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—MAOA—conduct disorder	0.000872	0.000872	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—EP300—conduct disorder	0.000763	0.000763	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—COMT—conduct disorder	0.000761	0.000761	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—MAOA—conduct disorder	0.000756	0.000756	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000733	0.000733	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—COMT—conduct disorder	0.000679	0.000679	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—MAOA—conduct disorder	0.000674	0.000674	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—EP300—conduct disorder	0.000664	0.000664	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—COMT—conduct disorder	0.000663	0.000663	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—MAOA—conduct disorder	0.000658	0.000658	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000654	0.000654	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—COMT—conduct disorder	0.000625	0.000625	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—MAOA—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—EP300—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—COMT—conduct disorder	0.000619	0.000619	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—MAOA—conduct disorder	0.000615	0.000615	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000596	0.000596	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—EP300—conduct disorder	0.000568	0.000568	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—EP300—conduct disorder	0.000521	0.000521	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—COMT—conduct disorder	0.000408	0.000408	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—MAOA—conduct disorder	0.000406	0.000406	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—EP300—conduct disorder	0.000385	0.000385	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—EP300—conduct disorder	0.000377	0.000377	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—EP300—conduct disorder	0.000326	0.000326	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—EP300—conduct disorder	0.000291	0.000291	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—EP300—conduct disorder	0.000284	0.000284	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—EP300—conduct disorder	0.000268	0.000268	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—EP300—conduct disorder	0.000266	0.000266	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—EP300—conduct disorder	0.000175	0.000175	CbGpPWpGaD
